Search Results - "Setchell, Kenneth"

Refine Results
  1. 1

    Equol: history, chemistry, and formation by Setchell, Kenneth D R, Clerici, Carlo

    Published in The Journal of nutrition (01-07-2010)
    “…Equol, first isolated from equine urine in 1932 and identified 50 years later in human urine as a metabolite of the soy isoflavones, daidzin and daidzein, is…”
    Get more information
    Journal Article
  2. 2

    Equol: pharmacokinetics and biological actions by Setchell, Kenneth D R, Clerici, Carlo

    Published in The Journal of nutrition (01-07-2010)
    “…Equol [7-hydroxy-3-(4'-hydroxyphenyl)-chroman], an isoflavan produced by intestinal bacteria in response to soy isoflavone intake in some but not all humans,…”
    Get more information
    Journal Article
  3. 3

    Method of defining equol-producer status and its frequency among vegetarians by Setchell, Kenneth D R, Cole, Sidney J

    Published in The Journal of nutrition (01-08-2006)
    “…7-Hydroxy-3-(4'-hydroxyphenyl)-chroman (S-equol) is a specific end-metabolite formed in the biotransformation of the dietary soy isoflavones daidzin and…”
    Get more information
    Journal Article
  4. 4

    The history and basic science development of soy isoflavones by Setchell, Kenneth D.R

    Published in Menopause (New York, N.Y.) (01-12-2017)
    “…ABSTRACTThis review summarizes the 2016 NAMS/Pfizer—Wulf H. Utian Endowed Lecture that focused on the history and basic science of soy isoflavones. Described…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Open‐label Phase 3 Continuation Study of Cholic Acid in Patients With Inborn Errors of Bile Acid Synthesis by Heubi, James E., Setchell, Kenneth D.R.

    “…ABSTRACT Background: In patients with bile acid synthesis disorders (BASD), impairment in the primary bile acid synthetic pathway leads to reduced primary bile…”
    Get full text
    Journal Article
  8. 8

    Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders by Heubi, James E., Bove, Kevin E., Setchell, Kenneth D.R.

    “…ABSTRACT Objectives: Patients with bile acid synthesis disorders (BASDs) due to single enzyme defects (SEDs) or Zellweger spectrum disorders (ZSDs) accumulate…”
    Get full text
    Journal Article
  9. 9

    Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice by Rao, Anuradha, Kosters, Astrid, Mells, Jamie E, Zhang, Wujuan, Setchell, Kenneth D R, Amanso, Angelica M, Wynn, Grace M, Xu, Tianlei, Keller, Brad T, Yin, Hong, Banton, Sophia, Jones, Dean P, Wu, Hao, Dawson, Paul A, Karpen, Saul J

    Published in Science translational medicine (21-09-2016)
    “…Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world, and safe and effective therapies are needed. Bile acids…”
    Get more information
    Journal Article
  10. 10

    Urinary sphingolipids in adolescents and young adults with youth-onset diabetes by Nehus, Edward J., Sheanon, Nicole M., Zhang, Wujuan, Marcovina, Santica M., Setchell, Kenneth D. R., Mitsnefes, Mark M.

    Published in Pediatric nephrology (Berlin, West) (01-06-2024)
    “…Background This study evaluated urinary sphingolipids as a marker of diabetic kidney disease (DKD) in adolescents and young adults with youth-onset type 1 and…”
    Get full text
    Journal Article
  11. 11

    The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones by Setchell, Kenneth D R, Brown, Nadine M, Lydeking-Olsen, Eva

    Published in The Journal of nutrition (01-12-2002)
    “…Equol [7-hydroxy-3-(4'-hydroxyphenyl)-chroman] is a nonsteroidal estrogen of the isoflavone class. It is exclusively a product of intestinal bacterial…”
    Get more information
    Journal Article
  12. 12

    Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk by DR SETCHELL, Kenneth, BROWN, Nadine M, XUEHENG ZHAO, LINDLEY, Stephanie L, HEUBI, James E, KING, Eileen C, MESSINA, Mark J

    Published in The American journal of clinical nutrition (01-11-2011)
    “…Human and animal studies have produced conflicting results with regard to the effect of soy isoflavones on breast cancer risk. This may be due to differences…”
    Get full text
    Journal Article
  13. 13

    Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology by Sun, Ying, Florer, Jane, Mayhew, Christopher N, Jia, Zhanfeng, Zhao, Zhiying, Xu, Kui, Ran, Huimin, Liou, Benjamin, Zhang, Wujuan, Setchell, Kenneth D R, Gu, Jianguo, Grabowski, Gregory A

    Published in PloS one (30-03-2015)
    “…Gaucher disease (GD) is caused by insufficient activity of acid β-glucosidase (GCase) resulting from mutations in GBA1. To understand the pathogenesis of the…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Inborn Errors of Bile Acid Metabolism by Heubi, James E., MD, Setchell, Kenneth D.R., PhD, Bove, Kevin E., MD

    Published in Clinics in liver disease (01-11-2018)
    “…Inborn errors of bile acid metabolism are rare causes of neonatal cholestasis and liver disease in older children and adults. The diagnosis should be…”
    Get full text
    Journal Article
  17. 17

    Weight Loss Induced by Roux-en-Y Gastric Bypass But Not Laparoscopic Adjustable Gastric Banding Increases Circulating Bile Acids by Kohli, Rohit, Bradley, David, Setchell, Kenneth D, Eagon, J. Christopher, Abumrad, Nada, Klein, Samuel

    “…Context: It has been hypothesized that increased plasma bile acids (BAs) contribute to metabolic improvements after Roux-en-Y gastric bypass (RYGB) surgery by…”
    Get full text
    Journal Article
  18. 18

    Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease by El Kasmi, Karim C, Anderson, Aimee L, Devereaux, Michael W, Vue, Padade M, Zhang, Wujuan, Setchell, Kenneth D R, Karpen, Saul J, Sokol, Ronald J

    Published in Science translational medicine (09-10-2013)
    “…Parenteral nutrition-associated liver disease (PNALD) is a serious complication of PN in infants who do not tolerate enteral feedings, especially those with…”
    Get more information
    Journal Article
  19. 19

    PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, GBA1 mutation-associated pathologies and diseases by Zhao, Xiangli, Lin, Yi, Liou, Benjamin, Fu, Wenyu, Jian, Jinlong, Fannie, Venette, Zhang, Wujuan, Setchell, Kenneth D R, Grabowski, Gregory A, Sun, Ying, Liu, Chuan-Ju

    “…Mutations in , encoding glucocerebrosidase (GCase), cause Gaucher disease (GD) and are also genetic risks in developing Parkinson's disease (PD). Currently,…”
    Get full text
    Journal Article
  20. 20

    Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight‐loss‐independent manner by Myronovych, Andriy, Kirby, Michelle, Ryan, Karen K., Zhang, Wujuan, Jha, Pinky, Setchell, Kenneth DR, Dexheimer, Phillip J., Aronow, Bruce, Seeley, Randy J., Kohli, Rohit

    Published in Obesity (Silver Spring, Md.) (01-02-2014)
    “…Objective Our objective was to investigate the role of bile acids in hepatic steatosis reduction after vertical sleeve gastrectomy (VSG). Design and Methods…”
    Get full text
    Journal Article